Scholastic shares dive after hours on worse-than-expected quarterly loss
Shares of Scholastic Corp. (SCHL) slid 12.7% after hours on Thursday after the children's book publisher reported a worse-than-expected loss for the second quarter and held to its full-year outlook. The company reported a fiscal first-quarter net loss of $74.2 million, or $2.35 a share, compared with a loss of $45.4 million, or $1.33 a share, in the same quarter last year. Revenue fell to $228.5 million from $262.9 million in the prior-year quarter. Scholastic's adjusted loss per share was $2.20. Analysts polled by FactSet expected Scholastic to report an adjusted loss of $1.35 a share, on revenue of $268.8 million. Management attributed the results to the summer school break, when the company typically loses money, and "the timing of revenues from state-sponsored programs." Scholastic said it expected full-year sales to benefit from fall releases like a new installment of Dav Pilkey's "Cat Kid Comic Club," an interactive MinaLima edition of "Harry Potter and the Prisoner of Azkaban," and the release of the "Goosebumps" TV series on Disney+ and Hulu.
-Bill Peters
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-21-23 1639ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?